Cantor Fitzgerald restated their overweight rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a research note released on Wednesday, Benzinga reports. Cantor Fitzgerald currently has a $65.00 target price on the stock. A number of other brokerages have also issued reports on BCYC. B. Riley raised Bicycle Therapeutics from a neutral rating […]
Bicycle Therapeutics plc Forecasted to Earn FY2023 Earnings of ($5.24) Per Share (NASDAQ:BCYC) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) was the recipient of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 4,430,000 shares, a drop of 7.3% from the September 30th total of 4,780,000 shares. Based on an average daily volume of 349,000 shares, […]
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average […]
B. Riley upgraded shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) from a neutral rating to a buy rating in a report published on Monday, MarketBeat.com reports. B. Riley currently has $33.00 price objective on the stock. Several other analysts have also recently commented on BCYC. HC Wainwright reiterated a buy rating and set a […]